CXCL13 and Lyme disease: In the present study, CXCL13 –which was part of the neurology panel and has been proposed as a biomarker of neuroborreliosis, especially in children, and is released by monocytes following exposure to the outer surface proteins from Borrelia–was in the present study not identified among the investigated patients [36].